Maternal obesity and metabolic risk to the offspring: Why lifestyle interventions may have not achieved the desired outcomes

International Journal of Obesity

Volumn 39, Issue 4, 2015, Pages 642-649

  Catalano, P ^a   Demouzon, S H ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; GLUCOSE BLOOD LEVEL;

ADAPTATION; ADIPOSE TISSUE; BODY MASS; DIET; ENDOCRINE FUNCTION; FETUS GROWTH; FIRST TRIMESTER PREGNANCY; GENE EXPRESSION; HUMAN; LIFESTYLE MODIFICATION; LIPOGENESIS; MACROSOMIA; MATERNAL OBESITY; METABOLIC DISORDER; NEONATAL OBESITY; OBESITY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PLACENTA; PLACENTA FUNCTION; PRACTICE GUIDELINE; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROGENY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK; WEIGHT GAIN; ADULT; BIRTH WEIGHT; BODY COMPOSITION; COMPLICATION; DIABETES, GESTATIONAL; FEMALE; GLUCOSE BLOOD LEVEL; MALE; METABOLISM; MOTHER; PREGNANCY COMPLICATIONS; RISK REDUCTION; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADULT; BIRTH WEIGHT; BLOOD GLUCOSE; BODY COMPOSITION; BODY MASS INDEX; DIABETES, GESTATIONAL; FEMALE; HUMANS; MALE; MOTHERS; OBESITY; PREGNANCY; PREGNANCY COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK REDUCTION BEHAVIOR; UNITED STATES; WEIGHT GAIN;

EID: 84927006747     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2015.15     Document Type: Review

References (78)

1. Catalano PM. Increasing maternal obesity and weight gain during pregnancy: the obstetric problems of plentitude. Obstet Gynecol 2007; 110: 743-744.
2. World Health Organization. Obesity: Preventing and managing the global epidemic. World Health Organization: Geneva, 2000; 894.
3. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 2014; 311: 806-814.
4. Lindsay CA, Huston L, Amini SB, Catalano PM. Longitudinal changes in the relationship between body mass index and percent body fat in pregnancy. Obstet Gynecol 1997; 39: 337-382.
5. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010; 303: 235-241.
6. FLegal KM, Carroll MD, Kit BK, Ogden CL. Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010. JAMA 2012; 307: 491-497.
7. Ogden CL, Carroll MD, Kit BK, Flegal KM. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA 2012; 307: 483-490.
8. Ananth CV, Wen SW. Trends in fetal growth among singleton gestations in the United States and Canada, 1985 through 1998. Semin Perinatol 2002; 26: 260-267.
9. Surkan PJ, Hsieh CC, Johansson AL, Dickman PW, Cnattingius S. Reasons for increasing trends in large for gestational age births. Obstet Gynecol 2004; 104: 720-726.
10. Catalano PM. Management of obesity in pregnancy. Obstet Gynecol 2007; 109: 419-433.
11. Donahue SMA, Kleinman KP, Gillman MW, Oken E. Trends in birth weight and gestational length among singleton term births in the United States: 1990-2005. Obstet Gynecol 2010; 115: 357-364.
12. Gibson KS, Waters T, Catalano PM. Factors relating to national trends in decreasing birth weight in term singleton deliveries. Society for Gynecologic Investigation 2011; 18 (Suppl): 210A (abstract F130).
13. Institute of Medicine. Weight gain during pregnancy: reexamining the guidelines. National Academy Press: Washington, DC, 2009.
14. Chu SY, Callaghan WM, Bish CL, D'Angelo D. Gestational weight gain by body mass index among US women delivering live births, 2004-2005: fueling future obesity. Am J Obstet Gynecol 2009; 200: 271.e1-271.e7.
15. Artal R, Lockwood CJ, Brown HL. Weight gain recommendations in pregnancy and the obesity epidemic. Obstet Gynecol 2010; 115: 152-155.
16. Catalano PM, Mele L, Landon MB, Ramin SM, Reddy UM, Casey B et al. For the Eunice Kennedy Shriver NICHHD Maternal-Fetal Medicine Units Network. Inadequate weight gain in overweight and obese pregnancy women: what is the effect on fetal growth? Am J Obstet Gynecol 2014; 211: 137.e1-137.e7.
17. Rasmussen KM, Abrams B, Bodnar LM, Butt NF, Catalano PM, Siega-Riz AM. Recommendations for weight gain during pregnancy in the context of the obesity epidemic. Obstet Gynecol 2010; 116: 1191-1195.
18. Whitaker RC. Predicting preschooler obesity at birth: the role of maternal obesity in early pregnancy. Pediatrics 2004; 114: e29-e36.
19. Boney CM, Verma A, Tucker R, Wohr BR. Metabolic syndrome in childhood: Association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005; 115: e290-e296.
20. Dabelea D, Mayer-Davis EJ, Lamichhane AP, D'Agostino RB Jr., Liese AD, Vehik KS et al. Association of intrauterine exposure to maternal diabetes and obesity with type 2 diabetes in youth. The SEARCH case-control study. Diabetes Care 2008; 31: 1422-1426.
21. Sewell MF, Huston-Presley L, Super DM, Catalano PM. Increased neonatal fat mass, not lean body mass, is associated with maternal obesity. AJOG 2006; 195: 1100-1103.
22. Catalano PM, Farrell K, Thomas A, Huston-Presley L, Mencin P, Hauguel-de Mouzon S et al. Perinatal risk factors for childhood obesity and metabolic dysregulation. Am J Clin Nutr 2009; 90: 1303-1313.
23. Phillips LH, Santhakumaran S, Gale C, Prior E, Logan KM, Hyde MJ et al. The diabetic pregnancy and offspring BMI in childhood: A systematic review and meta-analysis. Diabetologia 2011; 54: 1957-1966.
24. WIN Weight-Control Information Network. Prescription medications for the treatment of obesity. NIDDK 2013; 1-8.
25. Rowan JA, Hague WM, Gao W, Battin MR, Moore MP. For the MiG Trial Investigators. Metformin versus insulin for the treatment of gestational diabetes. N Engl J Med 2008; 358: 2003-2015.
26. Moses RG, Casey SA, Quinn EG, Cleary JM, Tapsell LC, Milosavljevic M et al. Pregnancy and glycemic index outcomes study: effects of low glycemic index compared with conventional dietary advice on selected pregnancy outcomes. AM J Clin Nutr 2014; 99: 517-523.
27. Santos IA, Stein R, Fuchs SC, Duncan BB, Ribeiro JP, Droeff LR et al. Aerobic exercise and submaximal functional capacity in overweight pregnancy women. Obstet Gynecol 2005; 106: 243-249.
28. Vinter CA, Jensen DM, Ovesen P, Beck-Nielsen H, Jørgensen JS. The LiP (Lifestyle in Pregnancy) Study. A randomized controlled trial of lifestyle intervention in 360 obese pregnancy women. Diabetes Care 2011; 34: 2502-2507.
29. Dodd JM, Turnbull D, McPhee A, Deussen AR, Grivell RM, Yelland LN et al. for the LIMIT Randomised Trial group. Antenatal lifestyle advice for women who are overweight or obese: LIMIT randomised trial. BMJ 2014; 348: g1285.
30. Ilmonen J, Isolauri E, Poussa T, Laitinen K. Impact of dietary counselling and probiotic intervention on maternal anthropometric measurements during and after pregnancy: A randomized placebo-controlled trial. Clin Nutr 2011; 30: 156-164.
31. Muktabhant B, Lumbiganon P, Ngamjarus C, Dowswell T. Interventions for preventing excessive weight gain during pregnancy. Cochrane Database Syst Rev 2012; 4: CD007145.
32. Thangaratinam S, Rogozi?ska E, Jolly K, Roseboom T, Tomlinson JW, Kunz R et al. Effects of interventions in pregnancy on maternal weight and obstetric outcomes: metaanalysis of randomized evidence. BMJ 2012; 344: e2088-e2102.
33. Walsh JM, McGowan CA, Mahony R, Foley ME, McAuliffe FM. Low glycemic index diet in pregnancy to prevent macrosomia (ROLO study): randomized control trial. BMJ 2012; 345: e5605.
34. Renault KM, Norgaard K, Nilas L, Carlsen E, Cortes D, Pryds O et al. The Treatment of Obese Pregnancy Women (TOP) study: A randomized controlled trial of the effect of physical activity intervention assessed by pedometer with or without dietary intervention in obese pregnant women. Am J Obstet Gynecol 2014; 210: 134.e1-134.e9.
35. Dodd JM, Grivell RM, Crowther CA, Robinson JS. Antenatal interventions for overweight or obese pregnant women: A systematic review of randomized trials. BJOG 2010; 117: 1316-1326.
36. Tanentsapf I, Heitmann BL, Adegboye ARA. Systematic review of clinical trials on dietary interventions to prevent excessive weight gain during pregnancy among normal weight, overweight and obese women. BMC Pregnancy Childbirth 2011; 11: 81.
37. Quinlivan JA, Julania S, Lam L. Antenatal dietary interventions in obese pregnant women to restrict gestational weight gain to Institute of Medicine recommendations. A metaanalysis. Obstet Gynecol 2011; 118: 1395-1401.
38. Thangaratinam S, Jolly K. Obesity in pregnancy: A review of reviews on the effectiveness of interventions. BJOG 2010; 117: 1309-1312.
39. Han S, Middleton P, Crowther CA. Exercise for pregnant women for preventing gestational diabetes mellitus. Cochrane Database Syst Rev 2012; 7: CD009021.
40. Battaglia FC, Meschia G. Principal substrates of fetal metabolism. Physiol Rev 1978; 58: 499-527.
41. Okereke NC, Huston-Presley L, Amini SB, Kalhan S, Catalano PM. Longitudinal changes in energy expenditure and body composition in obese women with normal and impaired glucose tolerance. Am J Physiol Endocrinol Metab 2004; 287: E472-E479.
42. Ryan EA, O'Sullivan MJ, Skyler JS. Insulin action during pregnancy. Studies with the euglycemic clamp technique. Diabetes 1985; 34: 380-389.
43. Knopp RH, Warth MR, Carrol CJ. Lipid metabolism in pregnancy. I. Changes in lipoprotein triglyceride and cholesterol in normal pregnancy and the effects of diabetes mellitus. J Reprod Med 1975; 10: 95-101.
44. Catalano PM, Ehrenberg HM. The short-and long-term implications of maternal and obesity on the mother and her offspring. BJOG 2006; 113: 1126-1133.
45. Catalano PM, Drago NM, Amini SB. Factors affecting fetal growth and body composition. Am J Obstet Gynecol 1995; 172: 1459-1463.
46. Herrera E. Metabolic adaptations in pregnancy and their implications for the availability of substrates to the fetus. Eur J Clin Nutr 2000; 54 (Suppl 1): S47-S51.
47. Meyer BJ, Stewart FM, Brown EA, Cooney J, Nilsson S, Olivecrona G et al. Maternal obesity is associated with the formation of small dense LDL and hypoadiponectinemia in the third trimester. J Clin Endocrinol Metab 2013; 98: 643-652.
48. Pepe G, Albrecht E. Glob libr. Women's Med. Steroid Endocrinology of Pregnancy (ISSN: 1756-2228) 2008. doi:10.3843/GLOWM.10311.
49. Catalano PM, Hauguel-De Mouzon S. Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic? Am J Obstet Gynecol 2011; 204: 479-487.
50. Resi V, Basu S, Haghiac M, Presley L, Minium J, Kaufman B et al. Molecular inflammation and adipose tissue matrix remodeling precede physiological adaptations to pregnancy. Am J Physiol Endocrinol Metab 2012; 303: E832-E840.
51. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, Challier JC, Huston-Presley L, Friedman JE et al. TNF-alpha is a predictor of insulin resistance in human pregnancy. Diabetes 2002; 51: 2207-2213.
52. Zhang L, Sugiyama T, Murabayashi N, Umekawa T, Ma N, Kamimoto Y et al. The inflammatory changes of adipose tissue in late pregnant?mice. J Mol Endocrinol 2011; 47: 157-165.
53. Highman TJ, Friedman JE, Huston LP, Wong WW, Catalano PM. Longitudinal changes in maternal serum leptin concentrations, body composition, and resting metabolic rate in pregnancy. Am J Obstet Gynecol 1998; 178: 1010-1015.
54. Catalano PM, Hoegh M, Minium J, Huston-Presley L, Bernard S, Kalhan S et al. Adiponectin in human pregnancy: implications for regulation of glucose and lipid metabolism. Diabetologia 2006; 49: 1677-1685.
55. Hauguel-de Mouzon S, Lepercq J, Catalano P. The known and unknown of leptin in pregnancy. Am J Obstet Gynecol 2006; 194: 1537-1545.
56. Considine R, Sinha M, Heiman M. Serum immunoreactive leptin concentrations in normalweight and obese?humans. N Engl J Med 1996; 334: 292-295.
57. Fruhbeck G, Jebb SA, Prentice AM. Leptin: physiology and pathophysiology. Clin Physiol 1998; 18: 399-419.
58. Haghiac M, Basu S, Presley L, Serre D, Catalano PM, Hauguel-de Mouzon S. Patterns of adiponectin expression in term pregnancy; impact of obesity. J Clin Endorinol Metab 2014; 99: 3427-3434.
59. Karki S, Chakrabarti P, Huang G, Wang H, Farmer SR, Kandror KV. The multi-level action of fatty acids on adiponectin production by fat?cells. PLoS One 2011; 6: e28146.
60. Ranheim T, Haugen F, Staff AC, Braekke K, Harsem NK, Drevon CA. Adiponectin is reduced in gestational diabetes mellitus in normal weight?women. Acta Obstet Gynecol Scand 2004; 83: 341-347.
61. Lee JY, Ye J, Gao Z, Youn HS, Lee WH, Zhao L et al. Reciprocal modulation of Toll-like receptor-4 signaling pathways involving MyD88 and phosphatidylinositol 3-kinase/AKT by saturated and polyunsaturated fatty?acids. J Biol Chem 2003; 278: 37041-37051.
62. Shi H, Kokoeva MV, Inouye K, Tzameli I, Yin H, Flier J. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006; 116: 3015-3025.
63. Jarvie E, Hauguel-de Mouzon S, Nelson SM, Sattar N, Catalano M, Freeman DJ. Lipotoxicity in obese pregnancy and its potential role in adverse pregnancy outcome and obesity in the offspring. Clin Sci (London, Engl) 2010; 119: 123-129.
64. Wong GW, Wang J, Hug C, Tsao TS, Lodish HF. A family ofAcrp30/adiponectin structural and functional paralogs. The exclusive expression and mechanism of action AdpN may be partly influenced by the presence of a distinctive TNF?-like globular?domain. Proc Natl Acad Sci USA 2004; 101: 10302-10307.
65. Lihn AS, Bruun JM, He G, Pedersen SB, Jensen PF, Richelsen B. Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol 2004; 219: 9-15.
66. Hauguel-de Mouzon S, Guerre-Millo M. The placenta cytokine network and inflammatory signals. Placenta 2006; 27: 794-798.
67. Lepercq J, Cauzac M, Lahlou N, Timsit J, Girard J, Auwerx J et al. Overexpression of placental leptin in diabetic pregnancy: A critical role for insulin. Diabetes 1998; 47: 847850.
68. Corbetta S, Bulfamante G, Cortelazzi D, Barresi V, Cetin I, Mantovani G et al. Diponectin expression in human fetal tissues during mid- and late gestation. J Clin Endocrinol Metab 2005; 90: 2397-2402.
69. Yamauchi T, Nio Y, Maki T, Kobayashi M, Takazawa T, Iwabu M et al. Targeted disruption of adipoR1 and adipoR2 causes abrogation of adiponectin binding and metabolic actions. Nature Med 2007; 13: 332-339.
70. Rosario FJ, Schumacher MA, Jiang J, Kanai Y, Powell TL, Jansson T. Chronic maternal infusion of full-length adiponectin in pregnant mice down-regulates placental amino acid transporter activity and expression and decreases fetal? growth. J Physiol 2012; 590: 1495-1509.
71. Jones HN, Jansson T, Powell TL. Full length adiponectin attenuates insulin signaling and inhibits insulin-stimulated amino acid transport in human primary trophoblast?cells. Diabetes 2010; 59: 1161-1170.
72. McDonald EA, Wolfe MW. Adiponectin attenuation of endocrine function within human term trophoblast?cells. Endocrinology 2009; 150: 4358-4365.
73. Gomes LL, Basu S, Minium J, Hauguel-de Mouzon S, Catalano P. Obesity in pregnancy is associated with decreased placental estradiol biosynthesis. Am J Obstet Gynecol 2014; 210(suppl): S32.
74. Sims EAH, Horton ES. Endocrine and metabolic adaptation to obesity and starvation. Am J Clin Nutr 1968; 21: 1355-1370.
75. Freinkel M, Cockroft DL, Lewis NJ, Gorman L, Akazawa S, Phillips LS et al. The 1986 McCollum award lecture. Fuel-mediated teratogenesis during early organogenesis: the effects of increased concentrations of glucose, ketones, or somatomedin inhibitor during rat embryo culture. Am J Clin Nutr 1986; 44: 986-995.
76. Gascoin G, Blackmore H, Musial B, Barnes S, Duque D, Ozanne SE et al. Exercise before and during an obese mouse pregnancy restores some placental gene expression and transport function. Early Nutrition 2014. Munich Germany. abstract 56.
77. Arun JA, Gavard JA, Cantanzaro RB, Artal R, Hopkins SA. The impact of interpregnancy weight change on birthweight in obese?women. Am J Obstet Gynecol 2013; 208: 205.e1-205.e7.
78. Rono K, Stach-Lempinen B, Klemetti MM, Kaaja RJ, Poyhonen M, Johan JG et al. Prevention of gestational diabetes through lifestyle intervention: Study design and methods of a Finnish randomized controlled trial multicenter trial (RADIEL). BMC Pregnancy Childbirth 2014; 14: 70.